Bispecific Drugs for Cancers
Exhibitor: CENTER FOR BIOMEDICAL RESEARCH AND DEVELOPMENT, NCKU
Booth No: N516
Characteristic
The existing drugs for glioblastoma and pancreatic cancer cannot effectively improve the overall survival rate of patients. We have successfully developed bispecific drugs targeting integrins and VEGFR2 pathways that can significantly reduce tumor growth and increase the survival rate. Our animal analyses showed that they are effective protein drugs for the treatments of glioblastoma and pancreatic cancer.
Other Products
-
Anti-fibrotic Drug Targeting ECM
-
Protein Production and GLP Laboratory
-
Fibrin and Platelet-targeting Thrombolytic Drug
-
Antithrombotic Drug with Low Risk of Bleeding
-
Modification Platforms for Protein Therapeutics
Highest Rated Products
-
2ton Mixing and Melting Tank with Storage Tanks
-
Planetary Vacuum Mixer
-
VACUUM EMULSIFY MIXING EQUIPMENT
-
Pneumatic Liquid Filling Machine
-
High Speed Mixing Machine
-
Powder Machine-High Speed Mixer / Granulator
-
VACUUM EMULSIFY MIXING EQUIPMENT (Bottom Homogenized Series)
-
SEMI-AUTOMATIC EYESHADOW PRESS MACHINE
-
In-Line Homogenizer
-
VACUUM EMULSIFY MIXING EQUIPMENT
-
Steel Basket-Strainer 20µm
-
NK Induction and Expansion Kit
-
PuraLev® SU Low Shear Single-Use Pump Systems
-
ABCcolla® Collagen Bone Graft
-
SOL Count, Lens-free automatic cell counter
-
CDMO
-
Cellabsys - SONICSTEM™ Non-contact Ultrasound device for Tissue Sonication
-
Exodus, Automatic exosome isolation system
-
GMP GLP GDP Life Science Engineering Services
-
WEARABLE STIMULATION DEVICE FOR STIMULATING DEEP MUSCLES OF ABDOMEN AND WAIST OF HUMAN BODY
-
EphA10-Trispecific Antibody of T & NK cell Engager
-
BLOOMNEST™ -Sialic acid
-
Prof. Ting-Wei Wang -- Wearable Pocket-Sized Fully Non-Contact Cardiorespiratory Sensor
-
EDA Low Laser Therapy Devices
-
Cell & Gene and Exosome therapy CDMO
-
ÜberStrainer 1 µm
-
ÜberStrainer 5µm
-
ÜberStrainer 10µm
-
ÜberStrainer 15µm
-
ÜberStrainer 20µm
